|
News and Achievements
Innovation Crescent fosters life sciences
Atlanta Business Chronicle, 09/12/08
Move over, Research Triangle Park — the Innovation Crescent is making its mark. The Innovation Crescent was unveiled this summer as the brand name for the geographic area extending from metro Atlanta to Athens. more
UGA scientists named distinguished cancer scholars
Atlanta Business Chronicle, 09/16/08
The Georgia Cancer Coalition has named The University of Georgia scientists John Vena, Jason Zastre and Claire Robb distinguished cancer scholars for 2008-09. Combined, the scientists will get about $1.3 million over five years to support their research through the coalition’s Distinguished Cancer Clinicians and Scientists program. The coalition picks scientists involved in the most promising areas of cancer research who can strengthen the state’s research talent, capacity, infrastructure and funding. more
Education efforts boost life sciences workforce
Atlanta Business Chronicle, 09/12/08
The first class of students graduated this summer from the Georgia Bioscience Technology Institute — bringing new biotech talent to the workforce. The institute, which is a partnership between Athens Technical College and Gwinnett Technical College, is one of many initiatives to grow the state’s life sciences workforce. The efforts range from stepping up science in middle schools to generating more college graduates and attracting esteemed scientists from other states. more
KPMG: Atlanta ranks high as tax-friendly area to businesses
Atlanta Business Chronicle, 07/28/08
Atlanta placed third in KPMG International’s analysis of major American cities with tax structures favorable to businesses. more
GaBio Supports Approval of H.S. Biotechnology Research and Development Career Pathway
ATLANTA, GA (July 14, 2008) – Georgia Bio applauds the State Board of Education for its approval of a high school curriculum for a Biotechnology Research and Development Career Pathway, scheduled for launch in the fall 2009. Initially approved under the Career, Technical and Agricultural Education (CTAE) Division, the courses are expected to be offered for science elective credit in the near future.
Developed under the state’s Healthcare Sciences track, the Biotechnology Research and Development Career Pathway contains three new biotechnology courses that will introduce students to modern concepts and techniques in biotechnology, and prepare them for entry level technician positions or post-secondary study. In addition to the existing Introduction to Healthcare Science course, the career pathway consists of an Introductory Biotechnology Course, an Applied Biotechnology Course, and an optional Internship/ Independent study course.
Georgia Bio assisted educators in developing the career pathway and is working with four county school districts within the Innovation Crescent to pilot the courses with funding from the Governor’s Office of Workforce Development. The Innovation Crescent is a 13-county region from Atlanta to Athens
“Approval of this high school career pathway by the state is a key step forward in Georgia’s development of a continuous, seamless system of training in the life sciences,” notes Charles Craig, president of Georgia Bio. “This capacity for lifelong learning is important for retaining and attracting the life sciences industry in our state.”
The Biotechnology Research and Development Career Pathway was identified as a priority based on the Governor Sonny Perdue’s strategic industries initiative. Curriculum teams, consisting of teachers (both academic and CTAE), post-secondary education faculty (Department of Technical and Adult Education and Board of Regents), business and industry representatives, and national curriculum experts worked with the Georgia Department of Education (GDOE) to develop performance standards for the CTAE curriculum.
“Biotechnology courses in the high school appeal to a broad range of high school students, with the hands-on approach motivating students to continue science-related training,” said James Woodard, CTAE Director for GDOE. “This curriculum will help local districts offer this training to meet the needs of their students and local industries.”
For more information on the newly approved pathway, visit the Georgia Department of Education website: www.georgiastandards.org/career.aspx?PageReq=HSPhaseIII
Georgia Bio represents over 330 pharmaceutical, biotech and medical device companies, universities, research institutes, government groups and other business organizations involved in the development of products that improve the health and quality of life people worldwide. For more information, visit www.gabio.org.
Company to raise $23M for reformulated drug
Atlanta Business Chronicle, 07/25/08
Wynden Pharmaceuticals Inc. plans to raise $23 million to test and eventually commercialize a drug targeted at the cardiology and oncology markets. The Alpharetta-based specialty pharmaceutical company, which employs about six, has changed the formulation of an existing nutritional supplement. more
Theragenics to acquire NeedleTech
Atlanta Business Chronicle, 07/18/08
Theragenics Corp. will buy NeedleTech Products Inc. in a $47.8 million cash deal. The deal should close in the third quarter of 2008, Buford, Ga.-based Theragenics (NYSE: TGX) said. more
HIV drug tests set for Phase 2
More hurdles ahead, but Atlanta's GeoVax says its vaccine shows 'significant promise.'
The Atlanta Journal-Constitution, 05/08/08
Despite the failure last fall of Merck & Co.'s AIDS vaccine, a fledgling Atlanta biotechnology company, GeoVax Inc., is charging ahead into advanced tests of a new drug that it says shows "significant promise."
"We've had excellent results in our early stage human trials," said Emory University's Harriet Robinson, leader of a team of scientists working on the vaccine. more
Sciele Pharma Announces That Addrenex Has Completed Enrollment of Pivotal Phase III Trial for Clonicel for ADHD
ATLANTA, June 3, 2008
Sciele Pharma, Inc. (NASDAQ: SCRX), a specialty pharmaceutical company, today announced that Addrenex Pharmaceuticals has completed patient enrollment of its first Phase III clinical trial in the U.S. for Clonicel to treat attention deficit and hyperactivity disorder (ADHD) in children. Addrenex is also continuing to enroll patients in an additional Phase III trial using Clonicel in combination with stimulants such as methylphenidate and dextro-amphetamine/amphetamine to treat ADHD. more
Altea Therapeutics Announces Positive Clinical Results for its Basal Insulin Transdermal Patch in Patients with Type 1 Diabetes
ATLANTA, Ga., October 30, 2007.
Altea Therapeutics has achieved sustained and steady basal levels of insulin in patients with type 1 diabetes using a small transdermal patch delivering recombinant human insulin in a cost-effective manner. These results were presented this week at the SMi 8th Annual Diabetes Conference held in London, United Kingdom. more
Emory Launches Joint Vaccine Center in India with International Biotechnology Center
ATLANTA, January 31, 2008
Two international leaders in vaccine science and technology--the Emory Vaccine Center and the International Center for Genetic Engineering and Biotechnology (ICGEB)--have joined forces to launch the Joint ICGEB-Emory Vaccine Center in New Delhi, India. more
USDA Grants Conditional Approval for First Therapeutic Vaccine to Treat Cancer
Merial's New Vaccine Treats Deadly Cancer in Dogs
DULUTH, GA, March 26, 200
Merial, the world's leading animal health company, gained conditional approval from the U.S. Department of Agriculture for a breakthrough vaccine to treat canine melanoma, a common yet deadly form of cancer in dogs. This is the first time that the U.S. government has approved a therapeutic vaccine for the treatment of cancer – in either animals or humans. more
CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic
ATLANTA, May 12
CryoLife, Inc. (NYSE: CRY), a biomaterials, medical device and tissue processing company, today announced the first implantation of the combination aortic-mitral allograft heart valve in a patient at the Cleveland Clinic. more
|
